Enhanced transport using membrane disruptive agents

CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 12/105,983, filed Apr. 18, 2008, which is a continuation of U.S. patent application Ser. No. 10/857,626, filed May 28, 2004 (now U.S. Pat. No. 7,374,778), which is a continuation of U.S. patent Ser. No. 09/226,044, filed Jan. 5, 1999 (now U.S. Pat. No. 6,835,393), which claims the benefit of U.S. Application No. 60/070,411, filed Jan. 5, 1998. Each application is incorporated herein by reference in its entirety.

front page icons

find-a-provider.pngwhat-we-treat2.pngmake a gift

Featured Video

Neurological Surgery Professor and Vice Chair, Laligam Sekhar was interviewed by KOMO News following the collapse of former Mariners baseball player, Danny Farquhar.